A new company is responsible for Japanese promotional activities for Actair, Stallergenes Greer’s sublingual immunotherapy ...

Stallergenes Greer, Shionogi & Co., Ltd. ("Shionogi") and CEOLIA Pharma Co. Ltd ("CEOLIA") today announced the transition of promotional activities for Actair® in Japan. Actair® is Stallergenes ...

This Research Topic is the second volume of the “Exploring Immunological Tolerance in Allergy Treatment through AIT” Community Series. Please see Volume I ...

From regularly hoovering to drying your clothes inside, here’s what you can do to keep symptoms at bay this summer ...

The precise use of immunotherapy agents in locally advanced head and neck squamous cell carcinoma has not been clearly delineated, even in phase 3 trials.

The survey highlights both the impact of the iPUMP® connected assistant and its strong adoption among patients undergoing sublingual liquid allergen immunotherapy (SLIT) treatment.

This online questionnaire, aimed at measuring the impact perceived by patients after three months of treatment with allergen immunotherapy (AIT) using Aptar Digital Health’s iPUMP® connected ...

Nearly half of Americans have some type of allergy. Are you one of them? Here's everything you need to know about if ...

Allergen immunotherapy (AIT)-induced anaphylaxis is rare and more likely to result from subcutaneous vs sublingual immunotherapy (SCIT vs SLIT).

Sublingual therapy was safe enough for all types of allergens under study, however, to achieve the same effect as the subcutaneous method of administration. In addition, oral immunotherapy has been ...